These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9803978)

  • 1. Therapeutic drug monitoring: antiarrhythmic drugs.
    Campbell TJ; Williams KM
    Br J Clin Pharmacol; 1998 Oct; 46(4):307-19. PubMed ID: 9803978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring: antiarrhythmic drugs.
    Campbell TJ; Williams KM
    Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):21S-34S. PubMed ID: 11564050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery.
    Bradley D; Creswell LL; Hogue CW; Epstein AE; Prystowsky EN; Daoud EG;
    Chest; 2005 Aug; 128(2 Suppl):39S-47S. PubMed ID: 16167664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic agents and proarrhythmia.
    Chaudhry GM; Haffajee CI
    Crit Care Med; 2000 Oct; 28(10 Suppl):N158-64. PubMed ID: 11055685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and mechanism of action of antiarrhythmic drugs.
    Scholz H
    Fundam Clin Pharmacol; 1994; 8(5):385-90. PubMed ID: 7875632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on antiarrhythmic drugs in emergency medicine.
    Stapczynski JS
    Emerg Med Clin North Am; 1988 May; 6(2):289-315. PubMed ID: 2894981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Lei M; Wu L; Terrar DA; Huang CL
    Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaughan Williams class IV antiarrhythmic drugs].
    Horie M; Washizuka T; Ikeguchi S; Sasayama S
    Nihon Rinsho; 1996 Aug; 54(8):2132-7. PubMed ID: 8810788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of antiarrhythmic drugs.
    Frumin H; Kerin NZ; Rubenfire M
    J Clin Pharmacol; 1989 May; 29(5):387-94. PubMed ID: 2661597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A benefit-risk assessment of class III antiarrhythmic agents.
    Brendorp B; Pedersen O; Torp-Pedersen C; Sahebzadah N; Køber L
    Drug Saf; 2002; 25(12):847-65. PubMed ID: 12241126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions.
    Nattel S; Singh BN
    Am J Cardiol; 1999 Nov; 84(9A):11R-19R. PubMed ID: 10568655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of Pharmacogenetic Information for Therapeutic Drug Monitoring of an Antiarrhythmic Drug].
    Doki K
    Yakugaku Zasshi; 2018; 138(9):1145-1150. PubMed ID: 30175758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The drug treatment of atrial fibrillation.
    Channer KS
    Br J Clin Pharmacol; 1991 Sep; 32(3):267-73. PubMed ID: 1685662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.